Skip to content
10-Q

Quarterly Report

ANTARES PHARMA, INC.

0001564590-21-041726

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 1, 2021 169.97M sh
Shares Diluted Q2 2021 · Jun 30, 2021 174.81M sh
Shares Diluted Q2 2021 · Jun 30, 2021 174.85M sh
Shares Diluted Q2 2021 · Jun 30, 2020 169.23M sh
Shares Diluted Q2 2021 · Jun 30, 2020 165.57M sh
Capex Q2 2021 · Jun 30, 2021 $2.46M
Capex Q2 2021 · Jun 30, 2020 $2.44M
Operating Cash Flow Q2 2021 · Jun 30, 2021 $8.41M
Operating Cash Flow Q2 2021 · Jun 30, 2020 $9.26M
Long Term Debt Q2 2021 · Jun 30, 2021 $3.34M
Long Term Debt Q2 2021 · Dec 31, 2020 $24.67M
Short Term Debt Q2 2021 · Jun 30, 2021 $22.81M
Short Term Debt Q2 2021 · Dec 31, 2020 $16.23M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $45.13M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $53.14M
Stockholders Equity Q2 2021 · Jun 30, 2021 $132.03M
Stockholders Equity Q2 2021 · Mar 31, 2021 $126.23M
Stockholders Equity Q2 2021 · Dec 31, 2020 $119.12M
Stockholders Equity Q2 2021 · Jun 30, 2020 $57.33M
Stockholders Equity Q2 2021 · Mar 31, 2020 $53.8M
Stockholders Equity Q2 2021 · Dec 31, 2019 $54.5M
Current Liabilities Q2 2021 · Jun 30, 2021 $71.98M
Current Liabilities Q2 2021 · Dec 31, 2020 $63.21M
Total Liabilities Q2 2021 · Jun 30, 2021 $80.59M
Total Liabilities Q2 2021 · Dec 31, 2020 $93.42M
Current Assets Q2 2021 · Jun 30, 2021 $127.96M
Current Assets Q2 2021 · Dec 31, 2020 $126.59M
Total Assets Q2 2021 · Jun 30, 2021 $212.62M
Total Assets Q2 2021 · Dec 31, 2020 $212.53M
Eps Diluted Q2 2021 · Jun 30, 2021 $0.03
Eps Diluted Q2 2021 · Jun 30, 2021 $0.05
Eps Diluted Q2 2021 · Jun 30, 2020 $0.01
Eps Diluted Q2 2021 · Jun 30, 2020 $0.00
Eps Basic Q2 2021 · Jun 30, 2021 $0.03
Eps Basic Q2 2021 · Jun 30, 2021 $0.05
Eps Basic Q2 2021 · Jun 30, 2020 $0.01
Eps Basic Q2 2021 · Jun 30, 2020 $0.00
Sga Expense Q2 2021 · Jun 30, 2021 $17.7M
Sga Expense Q2 2021 · Jun 30, 2021 $35.31M
Sga Expense Q2 2021 · Jun 30, 2020 $14.45M
Sga Expense Q2 2021 · Jun 30, 2020 $30.87M
Rd Expense Q2 2021 · Jun 30, 2021 $4.05M
Rd Expense Q2 2021 · Jun 30, 2021 $6.69M
Rd Expense Q2 2021 · Jun 30, 2020 $2.42M
Rd Expense Q2 2021 · Jun 30, 2020 $5.4M
Net Income Q2 2021 · Jun 30, 2021 $4.42M
Net Income Q2 2021 · Jun 30, 2021 $8.21M
Net Income Q2 2021 · Jun 30, 2020 $2.18M
Net Income Q2 2021 · Jun 30, 2020 −$181K
Operating Income Q2 2021 · Jun 30, 2021 $6.79M
Operating Income Q2 2021 · Jun 30, 2021 $12.18M
Operating Income Q2 2021 · Jun 30, 2020 $3.04M
Operating Income Q2 2021 · Jun 30, 2020 $1.67M
Revenue Q2 2021 · Jun 30, 2021 $44.98M
Revenue Q2 2021 · Jun 30, 2021 $87.06M
Revenue Q2 2021 · Jun 30, 2020 $32.38M
Revenue Q2 2021 · Jun 30, 2020 $65.46M